American College of Cardiology

Blomström-Lundqvist ET AL., MANAGEMENT OF PATIENTS WITH Supraventricular Arrhythmias
J Am Coll Cardiol 2003;42:1493–531

ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)

Tables and Figures

Figure 1. Afterdepolarizations from myocytes.

Figure 2. Initial evaluation of patients with suspected tachycardia.

Figure 3. Differential diagnosis for narrow QRS tachycardia.

Figure 4. ECG pattern of typical AVNRT.

Figure 5. ECG tracing with limb leads I, II, and III, showing an RP (initial R to initial P) interval longer than the PR interval.

Figure 6. Responses of narrow complex tachycardias to adenosine.

Figure 7. Differential diagnosis for wide QRS-complex tachycardia (greater than 120 ms).

Figure 8. Electrocardiogram showing AV dissociation during VT in a patient with a wide QRS-complex tachycardia.

Figure 9. Acute management of patients with hemodynamically stable and regular tachycardia.

Figure 10. Surface ECG recording from leads V1, II, and V5 in a patient with focal junctional tachycardia.

Figure 11. Focal atrial tachycardia showing a long RP interval relationship.

Figure 12. 12-Lead ECG from a patient with counterclockwise cavotricuspid isthmus-dependent flutter.

Figure 13. 12-Lead ECG from a patient with clockwise cavotricuspid isthmus-dependent flutter.

Figure 14. Management of atrial flutter depending on hemodynamic stability.

Table 1. Epidemiological Trends in U.S. Medicare Hospitalizations for Supraventricular Arrhythmias—1991 to 1998

Table 2. HCUP-3 National Inpatient Sample of U.S. Community Hospital Discharge Data—1996

Table 3. Predisposing or Precipitating Factors for Patients With Palpitations

Table 4. Definitions of U.S. FDA Classification (Use in Pregnancy Setting

Table 5. Antiarrhythmic Drug Metabolism